000			02321 a2200697 4500
005			20250515135857.0
264		0	_c20081022
008			200810s 0 0 eng d
022			_a1460-2105
024	7		_a10.1093/jnci/djn309 _2doi
040			_aNLM _beng _cNLM
100	1		_aEllis, Matthew J
245	0	0	_aOutcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. _h[electronic resource]
260			_bJournal of the National Cancer Institute _cOct 2008
300			_a1380-8 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAged
650	0	4	_aAnalysis of Variance
650	0	4	_aAnastrozole
650	0	4	_aAntineoplastic Agents, Hormonal _xtherapeutic use
650	0	4	_aAromatase Inhibitors _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xanalysis
650	0	4	_aBreast Neoplasms _xchemistry
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aClinical Trials as Topic
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aKi-67 Antigen _xanalysis
650	0	4	_aLetrozole
650	0	4	_aLymphatic Metastasis
650	0	4	_aMiddle Aged
650	0	4	_aNeoadjuvant Therapy _xmethods
650	0	4	_aNeoplasm Staging
650	0	4	_aNitriles _xtherapeutic use
650	0	4	_aPostmenopause
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrognosis
650	0	4	_aProportional Hazards Models
650	0	4	_aReceptors, Estrogen _xanalysis
650	0	4	_aReproducibility of Results
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aTamoxifen _xtherapeutic use
650	0	4	_aTreatment Outcome
650	0	4	_aTriazoles _xtherapeutic use
700	1		_aTao, Yu
700	1		_aLuo, Jingqin
700	1		_aA'Hern, Roger
700	1		_aEvans, Dean B
700	1		_aBhatnagar, Ajay S
700	1		_aChaudri Ross, Hilary A
700	1		_avon Kameke, Alexander
700	1		_aMiller, William R
700	1		_aSmith, Ian
700	1		_aEiermann, Wolfgang
700	1		_aDowsett, Mitch
773	0		_tJournal of the National Cancer Institute _gvol. 100 _gno. 19 _gp. 1380-8
856	4	0	_uhttps://doi.org/10.1093/jnci/djn309 _zAvailable from publisher's website
999			_c18279898 _d18279898